Asston Pharmaceuticals Ltd
NSE: BSE: 544445
₹81
(4.15%)
Fri, 08 May 2026, 05:34 pm
Market Cap662.01M
PE Ratio0
Dividend0
Asston Pharmaceuticals Cashflow
| Particulars | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Deprecation and amortization | -83.00K | -369.00K | -635.00K | -411.00K |
| Accumulated depreciation, total | -259.00K | -628.00K | -2.35M | -1.40M |
| Cash from operating activities | -16.20M | -10.24M | -46.93M | -9.26M |
| Funds from operations | 1.35M | 14.37M | 28.62M | 52.19M |
| Net income (cash flow) | 1.11M | 10.57M | 24.31M | 38.53M |
| Depreciation & amortization (cash flow) | 83.00K | 369.00K | 635.00K | 411.00K |
| Depreciation/depletion | 83.00K | 369.00K | 507.00K | — |
| Amortization | — | — | — | — |
| Deferred taxes (cash flow) | 0 | 0 | 0 | 0 |
| Non-cash items | -317.00K | -131.00K | -4.52M | 1.62M |
| Changes in working capital | -17.55M | -24.61M | -75.55M | -61.45M |
| Cash from investing activities | -22.00K | -9.24M | -455.00K | 6.82M |
| Capital expenditures | -22.00K | -2.51M | -103.00K | -271.00K |
| Capital expenditures - fixed assets | -22.00K | -2.51M | -103.00K | -271.00K |
| Capital expenditures - other assets | 0 | 0 | 0 | 0 |
| Cash from financing activities | 17.26M | 19.36M | 46.21M | 4.37M |
| Free cash flow | -16.22M | -12.75M | -47.03M | -9.53M |
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800